Diseases, Conditions, Syndromes

Modulating type 1 Interferon may expand treatment options for COVID-19

In their continuing work to limit the impact of COVID-19, Emory University researchers have, for the first time in nonhuman primates, studied how modulating the signaling of type 1 Interferon (IFN-I), one of the body's initial ...

page 3 from 25